BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Pang D, Li Y, Zhou J, Liu Y, Yang S, Liang K, Yu B. Serum miRNA biomarker discovery for placenta accreta spectrum. Placenta 2020;101:215-20. [PMID: 33017714 DOI: 10.1016/j.placenta.2020.09.068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Žarković M, Hufsky F, Markert UR, Marz M. The Role of Non-Coding RNAs in the Human Placenta. Cells 2022;11:1588. [PMID: 35563893 DOI: 10.3390/cells11091588] [Reference Citation Analysis]
2 Ming Y, Zeng X, Zheng T, Luo Q, Zhang J, Zhang L. Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: A multicenter hospital-based study. Placenta 2022. [DOI: 10.1016/j.placenta.2022.06.009] [Reference Citation Analysis]
3 Timofeeva AV, Fedorov IS, Pirogova MM, Vasilchenko ON, Chagovets VV, Ezhova LS, Zabelina TM, Shmakov RG, Sukhikh GT. Clusterin and Its Potential Regulatory microRNAs as a Part of Secretome for the Diagnosis of Abnormally Invasive Placenta: Accreta, Increta, and Percreta Cases. Life (Basel) 2021;11:270. [PMID: 33805203 DOI: 10.3390/life11040270] [Reference Citation Analysis]
4 Zhang T, Wang S. Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum. Front Med (Lausanne) 2022;9:860186. [PMID: 35712096 DOI: 10.3389/fmed.2022.860186] [Reference Citation Analysis]